Biomarker-guided immunomodulation in septic shock: navigating controversies and therapeutic implications for Critical Care - Quiz - MDSpire

Biomarker-guided immunomodulation in septic shock: navigating controversies and therapeutic implications for Critical Care

  • By

  • Yuxiu Dai

  • Hengyang Liu

  • Dingwen Xu

  • June 26, 2026

  • 0 min

Share

Original Source(s)

Biomarker-guided immunomodulation in septic shock: navigating controversies and therapeutic implications for Critical Care

  • by Yuxiu Dai, Hengyang Liu, Dingwen Xu

  • June 26, 2026

Related Content

Intranasal delivery of a polymeric nanoparticle subunit vaccine for the induction of protective immunity against respiratory syncytial virus

Clinical characteristics of Chlamydia pneumoniae pneumonia in 145 children: a single-centre retrospective study

Synergistic TCR-independent action of IL-33 and IL-12 drive a potent IFNγ secretory program in human circulating MAIT cells with immunomodulatory properties